Which of the following medications are classified as appetite stimulants for cancer patients?

Megace (megestrol acetate) and Marinol (dronabinol) are specifically classified as appetite stimulants, particularly beneficial for cancer patients who often experience appetite loss due to their illness or treatment side effects. Megace is a synthetic progestin that has been shown to increase appetite and improve weight gain in cancer cachexia, while Marinol, which contains THC, is derived from cannabis and is known to enhance appetite and reduce nausea, making it valuable for patients undergoing chemotherapy.

Other medication categories listed, such as chemotherapy drugs, are more focused on targeting cancer cells and do not primarily function as appetite stimulants. Pain relief medications can improve quality of life by alleviating discomfort but do not inherently stimulate appetite. Similarly, while some antidepressants can influence appetite, they vary in their effects and are not classified specifically as appetite stimulants for cancer patients.